Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5428]

Developing new radiotracers

Dr Stephen Paisey - Pre-Clinical Facilities Manager, PETIC, Cardiff, Wales

Developing new radiotracers ( Dr Stephen Paisey - Pre-Clinical Facilities Manager, PETIC, Cardiff, Wales )

What to expect from a PET scan

Mike De Wet - Radiographer, PETIC, Cardiff, Wales

What to expect from a PET scan ( Mike De Wet - Radiographer, PETIC, Cardiff, Wales )

Radiopharmaceutical production and their applications in the clinic

Dr Peter Llewelyn - Head of Production, PETIC, Cardiff, Wales

Radiopharmaceutical production and their applications in the clinic ( Dr Peter Llewelyn - Head of Production, PETIC, Cardiff, Wales )

ESMO 2017 highlights on managing difficult to treat cancers

Prof Richard Finn, Prof Viktor Grünwald, Prof Arndt Vogel, Prof René Adam

ESMO 2017 highlights on managing difficult to treat cancers ( Prof Richard Finn, Prof Viktor Grünwald, Prof Arndt Vogel, Prof René Adam )

ESMO 2017 roundup with Dr Bishal Gyawali (1/2)

Dr Bishal Gyawali - Nagoya University, Nagoya, Japan

ESMO 2017 roundup with Dr Bishal Gyawali (1/2) ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )

ESMO 2017 roundup with Dr Bishal Gyawali (2/2)

Dr Bishal Gyawali - Nagoya University, Nagoya, Japan

ESMO 2017 roundup with Dr Bishal Gyawali (2/2) ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )

Pembrolizumab falls short of endpoints in KEYNOTE 40

Dr Ezra Cohen - UC San Diego Health, San Diego, USA

Pembrolizumab falls short of endpoints in KEYNOTE 40 ( Dr Ezra Cohen - UC San Diego Health, San Diego, USA )

ARIEL3: Rucaparib as maintenance therapy in recurrent ovarian cancer patients

Prof Jonathan Ledermann - University College London Hospitals, London, UK

ARIEL3: Rucaparib as maintenance therapy in recurrent ovarian cancer patients ( Prof Jonathan Ledermann - University College London Hospitals, London, UK )

Initial results of inhibitor combination against breast and gynaecologic cancers

Dr Shannon Westin - MD Anderson Cancer Center, Houston, Texas

Initial results of inhibitor combination against breast and gynaecologic cancers ( Dr Shannon Westin - MD Anderson Cancer Center, Houston, Texas )

Patient empowerment and quality of life

Prof Françoise Meunier - Director General of EORTC, Brussels, Belgium

Patient empowerment and quality of life ( Prof Françoise Meunier - Director General of EORTC, Brussels, Belgium )

Chemoradiation remains best treatment for locally advanced cervical cancer

Prof Sudeep Gupta - Tata Memorial Hospital, Mumbai, India

Chemoradiation remains best treatment for locally advanced cervical cancer ( Prof Sudeep Gupta - Tata Memorial Hospital, Mumbai, India )

LORELEI trial of letrozole and taselisib for ER positive breast cancer

Dr Cristina Saura - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain

LORELEI trial of letrozole and taselisib for ER positive breast cancer ( Dr Cristina Saura - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain )

More from ecancer